Literature DB >> 1700822

Role of the gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA.

S Oertle1, P F Spahr.   

Abstract

Rous sarcoma virus nucleocapsid protein (NC) has been shown by site-directed mutagenesis to be involved in viral RNA packaging and in the subsequent maturation of genomic RNA in the progeny viral particles. To investigate whether NC exerts these activities as a free protein or as a domain of the polyprotein precursor Pr76gag, we have constructed several mutants unable to process Pr76gag and analyzed their properties in a transient-transfection assay of chicken embryo fibroblasts, the natural host of Rous sarcoma virus. A point mutation in the protease (PR) active site completely prevents Pr76gag processing. The full-length Pr76gag polyprotein is still able to package viral RNA, but cannot mature it. A shorter gag precursor polyprotein lacking the C-terminal PR domain, but retaining that of the NC protein, is however, unable even to package viral RNA. This indicates that the NC protein can participate in packaging viral RNA only as part of a full-length Pr76gag and that the PR domain is, indirectly or directly, also involved in RNA packaging. These results also demonstrate that processing of Pr76gag is necessary for viral RNA dimerization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700822      PMCID: PMC248723     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12. Mutation which affects RNA binding in vitro blocks viral replication.

Authors:  X D Fu; R A Katz; A M Skalka; J Leis
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

2.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Standardized and simplified nomenclature for proteins common to all retroviruses.

Authors:  J Leis; D Baltimore; J M Bishop; J Coffin; E Fleissner; S P Goff; S Oroszlan; H Robinson; A M Skalka; H M Temin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.

Authors:  C Méric; S P Goff
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codons.

Authors:  K M Lo; S S Jones; N R Hackett; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Site-specific phosphorylation of avian retrovirus nucleocapsid protein pp12 regulates binding to viral RNA. Evidence for different protein conformations.

Authors:  X Fu; N Phillips; J Jentoft; P T Tuazon; J A Traugh; J Leis
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

10.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

View more
  50 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal.

Authors:  J D Banks; M L Linial
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants.

Authors:  S Oertle; N Bowles; P F Spahr
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.

Authors:  H Burstein; D Bizub; M Kotler; G Schatz; V M Vogt; A M Skalka
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b.

Authors:  D J Anderson; P Lee; K L Levine; J S Sang; S A Shah; O O Yang; P R Shank; M L Linial
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression.

Authors:  A Moustakas; T S Sonstegard; P B Hackett
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.

Authors:  J L Certo; B F Shook; P D Yin; J T Snider; W S Hu
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.